April 12, 2005; 64 (7) Articles
Multiple Sclerosis Severity Score
Using disability and disease duration to rate disease severity
R. H.S.R. Roxburgh, S. R. Seaman, T. Masterman, A. E. Hensiek, S. J. Sawcer, S. Vukusic, I. Achiti, C. Confavreux, M. Coustans, E. le Page, G. Edan, G. V. McDonnell, S. Hawkins, M. Trojano, M. Liguori, E. Cocco, M. G. Marrosu, F. Tesser, M. A. Leone, A. Weber, F. Zipp, B. Miterski, J. T. Epplen, A. Oturai, P. Soelberg Sørensen, E. G. Celius, N. Téllez Lara, X. Montalban, P. Villoslada, A. M. Silva, M. Marta, I. Leite, B. Dubois, J. Rubio, H. Butzkueven, T. Kilpatrick, M. P. Mycko, K. W. Selmaj, M. E. Rio, M. Sá, G. Salemi, G. Savettieri, J. Hillert, D.A.S. Compston
First published April 11, 2005, DOI: https://doi.org/10.1212/01.WNL.0000156155.19270.F8
R. H.S.R. Roxburgh
S. R. Seaman
T. Masterman
A. E. Hensiek
S. J. Sawcer
S. Vukusic
I. Achiti
C. Confavreux
M. Coustans
E. le Page
G. Edan
G. V. McDonnell
S. Hawkins
M. Trojano
M. Liguori
E. Cocco
M. G. Marrosu
F. Tesser
M. A. Leone
A. Weber
F. Zipp
B. Miterski
J. T. Epplen
A. Oturai
P. Soelberg Sørensen
E. G. Celius
N. Téllez Lara
X. Montalban
P. Villoslada
A. M. Silva
M. Marta
I. Leite
B. Dubois
J. Rubio
H. Butzkueven
T. Kilpatrick
M. P. Mycko
K. W. Selmaj
M. E. Rio
M. Sá
G. Salemi
G. Savettieri
J. Hillert
Multiple Sclerosis Severity Score
Using disability and disease duration to rate disease severity
R. H.S.R. Roxburgh, S. R. Seaman, T. Masterman, A. E. Hensiek, S. J. Sawcer, S. Vukusic, I. Achiti, C. Confavreux, M. Coustans, E. le Page, G. Edan, G. V. McDonnell, S. Hawkins, M. Trojano, M. Liguori, E. Cocco, M. G. Marrosu, F. Tesser, M. A. Leone, A. Weber, F. Zipp, B. Miterski, J. T. Epplen, A. Oturai, P. Soelberg Sørensen, E. G. Celius, N. Téllez Lara, X. Montalban, P. Villoslada, A. M. Silva, M. Marta, I. Leite, B. Dubois, J. Rubio, H. Butzkueven, T. Kilpatrick, M. P. Mycko, K. W. Selmaj, M. E. Rio, M. Sá, G. Salemi, G. Savettieri, J. Hillert, D.A.S. Compston
Neurology Apr 2005, 64 (7) 1144-1151; DOI: 10.1212/01.WNL.0000156155.19270.F8
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 64 no. 7 1144-1151
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published April 11, 2005.
Copyright & Usage:
© 2005
Author Disclosures
- R. H.S.R. Roxburgh, FRACP*,
- S. R. Seaman, PhD*,
- T. Masterman, PhD,
- A. E. Hensiek, MRCP,
- S. J. Sawcer, PhD,
- S. Vukusic, PhD,
- I. Achiti, PhD,
- C. Confavreux, PhD,
- M. Coustans, PhD,
- E. le Page, PhD,
- G. Edan, PhD,
- G. V. McDonnell, MD,
- S. Hawkins, PhD,
- M. Trojano, PhD,
- M. Liguori, PhD,
- E. Cocco, PhD,
- M. G. Marrosu, PhD,
- F. Tesser, MD,
- M. A. Leone, MD,
- A. Weber, Dip Biol,
- F. Zipp, MD,
- B. Miterski, MD,
- J. T. Epplen, MD,
- A. Oturai, PhD,
- P. Soelberg Sørensen, PhD,
- E. G. Celius, PhD,
- N. Téllez Lara, PhD,
- X. Montalban, PhD,
- P. Villoslada, PhD,
- A. M. Silva, MD,
- M. Marta, MD,
- I. Leite, MD,
- B. Dubois, PhD,
- J. Rubio, PhD,
- H. Butzkueven, PhD,
- T. Kilpatrick, PhD,
- M. P. Mycko, MD,
- K. W. Selmaj, MD,
- M. E. Rio, PhD,
- M. Sá, PhD,
- G. Salemi, MD,
- G. Savettieri, MD,
- J. Hillert, PhD and
- D.A.S. Compston, PhD
- R. H.S.R. Roxburgh, FRACP*,
- S. R. Seaman, PhD*,
- T. Masterman, PhD,
- A. E. Hensiek, MRCP,
- S. J. Sawcer, PhD,
- S. Vukusic, PhD,
- I. Achiti, PhD,
- C. Confavreux, PhD,
- M. Coustans, PhD,
- E. le Page, PhD,
- G. Edan, PhD,
- G. V. McDonnell, MD,
- S. Hawkins, PhD,
- M. Trojano, PhD,
- M. Liguori, PhD,
- E. Cocco, PhD,
- M. G. Marrosu, PhD,
- F. Tesser, MD,
- M. A. Leone, MD,
- A. Weber, Dip Biol,
- F. Zipp, MD,
- B. Miterski, MD,
- J. T. Epplen, MD,
- A. Oturai, PhD,
- P. Soelberg Sørensen, PhD,
- E. G. Celius, PhD,
- N. Téllez Lara, PhD,
- X. Montalban, PhD,
- P. Villoslada, PhD,
- A. M. Silva, MD,
- M. Marta, MD,
- I. Leite, MD,
- B. Dubois, PhD,
- J. Rubio, PhD,
- H. Butzkueven, PhD,
- T. Kilpatrick, PhD,
- M. P. Mycko, MD,
- K. W. Selmaj, MD,
- M. E. Rio, PhD,
- M. Sá, PhD,
- G. Salemi, MD,
- G. Savettieri, MD,
- J. Hillert, PhD and
- D.A.S. Compston, PhD
- From the Neurology Department (Drs. Roxburgh, Sawcer, and Compston, and A.E. Hensiek), Cambridge University, UK; Auckland City Hospital (Dr. Roxburgh), New Zealand; Max Planck Institute for Psychiatry (Dr. Seaman), Munich, Germany; Division of Neurology (Drs. Masterman and Hillert), NEUROTEC, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden; EDMUS Coordinating Centre (Drs. Vukusic, Achiti, and Confavreux), Service de Neurologie A, Hôpital Neurologique, Lyon, France; Clinique Neurologique (Drs. Coustans, le Page, and Edan), Centre Hospitalier Universitaire de Rennes, Hôpital de Pontchaillou, France; Northern Ireland Regional Neurology Service (Drs. McDonnell and Hawkins), Royal Victoria Hospital, Belfast; Department of Neurological and Psychiatric Sciences (Drs. Trojano and Liguori), University of Bari, Italy; Department of Neuroscience (Drs. Cocco and Marrosu), Centro Sclerosi, Multipla University of Cagliari, Italy; Clinica Neurologica (Drs. Tesser and Leone), Università del Piemonte Orientale, “A. Avogadro,” Novara, Italy; Clinica Neurologica (Drs. Tesser and Leone), Ospedale Maggiore della Carità, Novara, Italy; Institut für Neuroimmunologie (A. Weber and Dr. Zipp), Klinische und Experimentelle Neuroimmunologie, Universitätsklinikum Charité, Neurowissenschaftliches Zentrum, Berlin; Abteilung für Humangenetik (Drs. Miterski and Epplen), Ruhr-Universität Bochum, Germany; Department of Neurology (Drs. Oturai and Soelberg Sørensen), Copenhagen University Hospital, Rigshospitalet, Denmark; Department of Neurology (Dr. Celius), Ullevål University Hospital, Oslo, Norway; Clinical Neuroimmunology Unit (Drs. Téllez Lara and Montalban), Vall D’Hebron, University Hospital, Barcelona, Spain; Multiple Sclerosis Centre (Dr. Villoslada), Department of Neurology, Clinica Universitaria de Navarra, Pamplona, Navarra, Spain; Neuroimmunology Group (Drs. Silva, Marta, and Leite), Department of Neurology, Hospital Geral Santo Antonio, Porto, Portugal; University Hospital Gasthuisberg (Dr. Dubois), University of Leuven, Belgium; The Walter and Eliza Hall Institute of Medical Research (Drs. Rubio, Butzkueven, and Kilpatrick), IG Royal Parade, Parkville, Victoria, Australia; The Cooperative Research Centre for Discovery of Genes for Common Human Diseases (Dr. Kilpatrick), Richmond, Victoria, Australia; Department of Neurology (Drs. Mycko and Selmaj), Medical University of Lodz, Poland; Neurology Department (Drs. Rio and Sá), Hospital de S. Joáo, Porto, Portugal; and Department of Neuropsichiatry (Drs. Salemi and Savettieri), Palermo, Italy.
- Address correspondence and reprint requests to Dr. R. Roxburgh, Neurology Dept., Cambridge University, Hills Rd., Cambridge CB2 2QQ, UK; e-mail: richard{at}roxburgh.net.nz
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Pediatric Multiple Sclerosis Severity Score in a large US cohortJonathan D. Santoro, Michael Waltz, Greg Aaen et al.Neurology, July 20, 2020 -
Articles
Cigarette smoking and progression in multiple sclerosisMarcus Koch, Annemarie van Harten, Maarten Uyttenboogaart et al.Neurology, October 08, 2007 -
Article
Phenome-wide examination of comorbidity burden and multiple sclerosis disease severityTingting Zhang, Matthew Goodman, Feng Zhu et al.Neurology: Neuroimmunology & Neuroinflammation, August 19, 2020 -
Article
Initial high-efficacy disease-modifying therapy in multiple sclerosisA nationwide cohort studyMathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg et al.Neurology, July 07, 2020